lunes, 3 de abril de 2017

Prescription Drug User Fee Act (PDUFA) > Public Meeting on Patient-Focused Drug Development for Sarcopenia

Prescription Drug User Fee Act (PDUFA) > Public Meeting on Patient-Focused Drug Development for Sarcopenia

FDA Template Logo

Masthead



PFDD

There's still time to register!
On April 6, 2017, FDA is conducting a public meeting on Patient-Focused Drug Development (PFDD) for Sarcopenia. FDA is interested in obtaining patient perspectives on the impact of Sarcopenia on daily life and patient views on treatment approaches.
Date: April 6, 2017
Time: 1:00 p.m. - 5:00 p.m.
Location: Tommy Douglas Conference Center, 10000 New Hampshire Avenue
Silver Spring, MD 20903
Registration: To register for this meeting, visit:  Patient-Focused Drug Development Public Meeting for Sarcopenia Event Brite website. Public Docket: In addition to providing input at the public meeting, stakeholders are invited to provide their perspectives on the discussion questions through the public docket. The docket closes on June 6, 2017.

Meeting Image
In this section you will find a comprehensive list of all the meetings that the FDA is involved with. The meetings may include advisory committee meetings, public workshops and public conferences that are seeking to hear from patients and caregivers.
Most FDA meetings are free to the public and do not require the public to register.  Interested persons may present data, information, or views, orally at the meeting, or in writing, on issues pending before the committee. Other types of meetings listed may require prior registration and fees.
  • Calendar of FDA Sponsored Public Meetings - April 2017
  • Calendar of FDA Sponsored Public Meetings - May 2017
 View FDA's Patient Network Calendar of Public Meetings page for a complete list of meetings and workshops.
Gray Pointer
For additional information on other agency meetings please visit Meetings, Conferences, & Workshops.

No hay comentarios:

Publicar un comentario